Augmented levels of macrophage and TH1 cell-related cytokine mRNA in submandibular glands of MRL/lpr mice with autoimmune sialoadenitis

Clinical and Experimental Immunology

Volumn 112, Issue 3, 1998, Pages 389-396

  Mustafa, W ^a   Zhu, J ^b   Deng, G ^b   Diab, A ^b   Link, H ^b   Frithiof, L ^a   Klinge, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokine mRNA; MRL lpr mice; Sialoadenitis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; CYTOLYSIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; OLIGONUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIALOADENITIS; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; MACROPHAGES; MICE; RNA, MESSENGER; SIALADENITIS; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; TH1 CELLS;

EID: 0031805910     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00609.x     Document Type: Article

References (42)

1. Bloch KJ, Buchanan WW, Wohl MJ et al. Sjögren's syndrome. A clinical, pathological and serological study of sixty-two cases. Med 1965; 44:187-231.
2. Fox RI, Robinson CA, Curd JG et al. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986; 29:577-85.
3. Talal N, Bunim JJ. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964; 36:529-40.
4. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 1971; 9:199-221.
5. Theophilopoulous AN, Balderas RS, Shawler DL et al. Influence of thymic genotype on the SLE-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med 1981; 153:1405-14.
6. Cohen PL, Eisenberg RA. Lpr and gld: single gene model of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9:243-69.
7. Hang L, Theofilopoulos AN, Bladeras RS et al. The effect of thymectomy on lupus-prone mice. J Immunol 1984; 132:1809-13.
8. Jabs DA, Burek CL, Hu Q et al. Anti-CD4 monoclonal antibody therapy suppresses autoimmune disease in MRL/Mp-lpr/lpr mice. Cell Immunol 1992; 141:496-507.
9. Sobel ES, Katagiri T, Katagiri K et al. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of autoimmunity. J Exp Med 1991; 173:1441-9.
10. Watanahe-Fukunaga R, Brannan CI, Copeland NG et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
11. Shlomchik MJ, Madaio MP, Ni D et al. The role of B cells in lpr/lpr induced autoimmunity. J Exp Med 1994; 180:1295-306.
12. Hoffman RW, Alspaugh MA, Waggie KS et al. Sjögren's syndrome in MRL/l and MRL/n mice. Arthritis Rheum 1984; 27:157-65.
13. Jonsson R, Tarkowski A, Bäckman K et al. Sialadenitis in the MRL/1 mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunol 1987; 60:611-6.
14. Jonsson R, Holmdahl R. Infiltrating mononuclear cells in salivary glands and kidneys in autoimmune MRL/lpr mice express IL-2 receptor and produce IFN-γ. J Oral Pathol 1990; 19:330-4.
15. Scott L, Wolff A, Fox PC. A histologic assessment of the submandibular glands in autoimmune-disease-prone mice. J Oral Pathol 1990; 19:131-5.
16. Hamano H, Saito I, Haneji N et al. Expression of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice. Fur J Immunol 1993; 23:2387-91.
17. Dagerlind A, Friberg K, Bean AL et al. Sensitive DNA detection using unfixed tissue: combined radioactive and nonradioactive in situ hybridisation histochemistry. Histochem 1992; 98:39-49.
18. Link J. Interferon-γ, interleukin-4 and transforming growth factor-β mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol Scand 1994; 90 (Suppl. 158):1-58.
19. Boswell JM, Yui MA, Burt DW et al. Increased tumour necrosis factor and IL-1β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141:3050-4.
20. Jacob CO, McDevitt HO. Tumor necrosis factor-α in murine autoimmune lupus nephritis. Nature 1988; 331:356-8.
21. Donelly RP, Levine J, Hartwell QD et al. Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice. J Immunol 1990; 145:3231-9.
22. Mizel SB. The interleukins. FASEB J 1989; 3:2379-88.
23. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5:517-31.
24. Hayashi H, Haneji N, Hamano H. Pathogenesis of Sjögren's syndrome-like lesions in MRL/lpr mice. Pathol Int 1994; 44:559-68.
25. Tarkowski A, Czerkinsky C, Nilsson LA. Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/lpr mice: a kinetic study. Clin Exp Immunol 1984; 58:7-12.
26. Duijvestijn AM, Schreiber AB, Butcher EC. Interferon-gamma regulates an antigen specific for endothelial cells involved in lymphocyte traffic. Proc Natl Acad Sci USA 1986; 83:9114-8.
27. Manetti R, Parronchi P, Guidizi MG et al. Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1992; 177:1199-204.
28. German T, Gately MK, Schoenhaut DS et al. Interleukin 12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur J Immunol 1993; 23:1762-70.
29. Young LH, Peterson LB, Wicker LS et al. In vivo expression of perforin by CD8 lymphocytes in autoimmune disease. Studies on spontaneous and adaptively transferred diabetes in nonobese diabetic mice. J Immunol 1989; 149:3994-9.
30. Wu Z, Podack ER, McKenzie JM et al. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin Exp Immunol 1994; 98:470-7.
31. Paul NL, Ruddle NH. Lymphotoxin. Annu Rev Immunol 1988; 6:407-38.
32. Cavander DE, Edelbaum D, Ziff M. Endothelial cell activation induced by tumour necrosis factor and lymphotoxin. Am J Pathol 1989; 134:551-60.
33. Yanagi K, Haneji N, Hamano H. et al. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice. Cell Immunol 1996; 168:243-50.
34. Vanroon JAG, Vanroy J, Gemligmeyling FHJ et al. Prevention and reversal of cartilage degradation by interleukin 10 and interleukin-4. Arthritis Rheum 1996; 39:829-35.
35. Brennan F, Feldman M. Cytokines in autoimmunity. Curr Opin Immunol 1996; 8:872-7.
36. Fontana A, Constam DB, Frei K et al. Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Immunol 1992; 99:1-7.
37. Sasaki H, Pollard RB, Schmitt D et al. Transforming growth factor-beta in the regulation of the immune response. Clin Immunol Immunopathol 1992; 65:1-9.
38. Mauri C, Williams RO, Walmsley M et al. Relationship between Th1/ Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511-8.
39. Powrie F, Leach MW. Genetic and spontaneous inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Theraputic Immunol 1995; 2:115-23.
40. Dolhain RJ, van der Heiden AN, ter Haar NT et al. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
41. Niessner M, Volk AB. Altered Th1/Th2 cytokine profile in the intestinal mucosa of patients of inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
42. Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granuloma: correlation with histopathologic features of the granulomatous response. J Immunol 1997; 159:3034-43.